Educational Session 1: Biomarker-guided Precision Therapy in Metastatic Breast Cancer 

Moderator

Philippe Bedard

Presentation numberED1-01

Actionable Mutations Beyond PIK3CA and ESR1 in HR Positive HER2 Negative Breast Cancer

Maria Coakley

Presentation numberED1-02

HER2-Low to HER2-Ultralow: Redefining HER2-Targeted Therapy

Shanu Modi

Presentation numberED1-03

Immune Biomarkers Driving Immunotherapy Selection in Metastatic TNBC

Giampaolo Bianchini

Advocate

Kelly Shanahan